Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2015 Jul 9

PMID 26154566

Citations 9

Authors

Miguel Munoz

Rafael Covenas

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer (PC) is the fourth leading cause of cancer related-deaths in both men and women, and the 1- and 5-year relative survival rates are 25% and 6%, respectively. It is known that smoking, alcoholism and psychological stress are risk factors that can promote PC and increase PC progression. To date, the prevention of PC is crucial because there is no curative treatment. After binding to the neurokinin-1 (NK-1) receptor (a receptor coupled to the stimulatory G-protein Gαs that activates adenylate cyclase), the peptide substance P (SP)-at high concentrations-is involved in many pathophysiological functions, such as depression, smoking, alcoholism, chronic inflammation and cancer. It is known that PC cells and samples express NK-1 receptors; that the NK-1 receptor is overexpressed in PC cells in comparison with non-tumor cells, and that nanomolar concentrations of SP induce PC cell proliferation. By contrast, NK-1 receptor antagonists exert antidepressive, anxiolytic and anti-inflammatory effects and anti-alcohol addiction. These antagonists also exert An antitumor action since in vitro they inhibit PC cell proliferation (PC cells death by apoptosis), and in a xenograft PC mouse model they exert both antitumor and anti-angiogenic actions. NK-1 receptor antagonists could be used for the treatment of PC and hence the NK-1 receptor could be a new promising therapeutic target in PC.

Citing Articles

Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer.

Liang Y, Li H, Gan Y, Tu H Front Cell Dev Biol. 2021; 9:688953.

PMID: 34395421 PMC: 8363299. DOI: 10.3389/fcell.2021.688953.

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity.

Legi A, Rodriguez E, Eckols T, Mistry C, Robinson P Cancers (Basel). 2021; 13(7).

PMID: 33917491 PMC: 8038801. DOI: 10.3390/cancers13071732.

The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways.

Javid H, Asadi J, Avval F, Afshari A, Hashemy S Mol Biol Rep. 2020; 47(3):2253-2263.

PMID: 32072401 DOI: 10.1007/s11033-020-05330-9.

miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.

Zhou Y, Wang M, Tong Y, Liu X, Zhang L, Dong D Technol Cancer Res Treat. 2019; 18:1533033819875168.

PMID: 31506061 PMC: 6740052. DOI: 10.1177/1533033819875168.

Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.

Ge C, Huang H, Huang F, Yang T, Zhang T, Wu H Proc Natl Acad Sci U S A. 2019; 116(39):19635-19645.

PMID: 31488714 PMC: 6765257. DOI: 10.1073/pnas.1908998116.

References

Binker M, Binker-Cosen A, Richards D, Gaisano H, de Cosen R, Cosen-Binker L . Chronic stress sensitizes rats to pancreatitis induced by cerulein: role of TNF-α. World J Gastroenterol. 2010; 16(44):5565-81. PMC: 2992674. DOI: 10.3748/wjg.v16.i44.5565. View

Seckl M, Higgins T, Rozengurt E . [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells. J Biol Chem. 1996; 271(46):29453-60. DOI: 10.1074/jbc.271.46.29453. View

Lieb K, Fiebich B, Berger M, Bauer J, Schulze-Osthoff K . The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol. 1997; 159(10):4952-8. View

Hargreaves R, Ferreira J, Hughes D, Brands J, Hale J, Mattson B . Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Ann N Y Acad Sci. 2011; 1222:40-8. DOI: 10.1111/j.1749-6632.2011.05961.x. View

Seckl M, Higgins T, Widmer F, Rozengurt E . [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells. Cancer Res. 1997; 57(1):51-4. View

Feng F, Yang J, Tong L, Yuan S, Tian Y, Hong L . Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells. Cell Biol Int. 2010; 35(6):623-9. DOI: 10.1042/CBI20100229. View

MacLeod S, Chowdhury P . The genetics of nicotine dependence: relationship to pancreatic cancer. World J Gastroenterol. 2006; 12(46):7433-9. PMC: 4087587. DOI: 10.3748/wjg.v12.i46.7433. View

Nakajima Y, Tsuchida K, Negishi M, Ito S, Nakanishi S . Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem. 1992; 267(4):2437-42. View

Li D, Xie K, Wolff R, Abbruzzese J . Pancreatic cancer. Lancet. 2004; 363(9414):1049-57. DOI: 10.1016/S0140-6736(04)15841-8. View

10.

Reeve J, Bleehen N . [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro. Biochem Biophys Res Commun. 1994; 199(3):1313-9. DOI: 10.1006/bbrc.1994.1374. View

11.

Gullo L, Barbara L, LABO G . Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology. 1988; 95(4):1063-8. DOI: 10.1016/0016-5085(88)90184-9. View

12.

Kim-Fuchs C, Le C, Pimentel M, Shackleford D, Ferrari D, Angst E . Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun. 2014; 40:40-7. PMC: 4102665. DOI: 10.1016/j.bbi.2014.02.019. View

13.

Howes N, Neoptolemos J . Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut. 2002; 51(6):765-6. PMC: 1773485. DOI: 10.1136/gut.51.6.765. View

14.

Momi N, Kaur S, Krishn S, Batra S . Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterol Dietol. 2012; 58(4):283-97. PMC: 3556910. View

15.

Covenas R, Munoz M . Cancer progression and substance P. Histol Histopathol. 2014; 29(7):881-90. DOI: 10.14670/HH-29.881. View

16.

Holzer P . Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988; 24(3):739-68. DOI: 10.1016/0306-4522(88)90064-4. View

17.

Sliwinska-Mosson M, Milnerowicz H . [Influence of tobacco smoking on lipase activity in patients with pancreatitis]. Przegl Lek. 2006; 62(10):1058-61. View

18.

Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi C . Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990; 40(2):264-78. DOI: 10.1016/0026-2862(90)90024-l. View

19.

Pezzilli R, Morselli-Labate A . Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain. Int J Environ Res Public Health. 2010; 6(11):2763-82. PMC: 2800061. DOI: 10.3390/ijerph6112763. View

20.

Lowenfels A, Maisonneuve P . Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006; 20(2):197-209. DOI: 10.1016/j.bpg.2005.10.001. View